Filtered By:
Source: American Heart Journal
Drug: Toprol
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
β-blocker dosage and outcomes after acute coronary syndrome
Conclusions In ACS patients, rates of MACE for high-dose and low-dose β-blocker doses are similar. These findings question the importance of achieving a high dose of β-blocker in ACS patients and highlight the need for further investigation of this clinical question.
Source: American Heart Journal - November 17, 2016 Category: Cardiology Source Type: research